LEX-WK-MSMH5CTGcrawled 2021-11-09 08:40Z
Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes
Caitlin M. Wilmot · Biosimilars Law Bulletin · Published April 3, 2018
Work details
- author
- Caitlin M. Wilmot
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Food, Drug & Agriculture
- published
- 2018-04-03
Citation
Caitlin M. Wilmot, Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes, Biosimilars Law Bulletin (April 3, 2018) [The Library at LexBlog, LEX-WK-MSMH5CTG, lexpid.org/MSMH5CTG]